Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Non-Current Debt (2018 - 2019)

Historic Non-Current Debt for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q2 2019 value amounting to $22.2 million.

  • X4 Pharmaceuticals' Non-Current Debt rose 18806.13% to $22.2 million in Q2 2019 from the same period last year, while for Jun 2019 it was $22.2 million, marking a year-over-year increase of 18806.13%. This contributed to the annual value of $8.3 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q2 2019, X4 Pharmaceuticals' Non-Current Debt is $22.2 million, which was up 18806.13% from $8.3 million recorded in Q4 2018.
  • In the past 5 years, X4 Pharmaceuticals' Non-Current Debt registered a high of $22.2 million during Q2 2019, and its lowest value of $7.7 million during Q2 2018.